Annual EBITDA
$1.69 B
+$573.00 M+51.16%
December 1, 2024
Summary
- As of February 26, 2025, XYL annual EBITDA is $1.69 billion, with the most recent change of +$573.00 million (+51.16%) on December 1, 2024.
- During the last 3 years, XYL annual EBITDA has risen by +$861.00 million (+103.49%).
- XYL annual EBITDA is now at all-time high.
Performance
XYL EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
$526.00 M
+$106.00 M+25.24%
December 1, 2024
Summary
- As of February 26, 2025, XYL quarterly EBITDA is $526.00 million, with the most recent change of +$106.00 million (+25.24%) on December 1, 2024.
- Over the past year, XYL quarterly EBITDA has increased by +$165.00 million (+45.71%).
- XYL quarterly EBITDA is now at all-time high.
Performance
XYL Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
$1.69 B
+$165.00 M+10.80%
December 1, 2024
Summary
- As of February 26, 2025, XYL TTM EBITDA is $1.69 billion, with the most recent change of +$165.00 million (+10.80%) on December 1, 2024.
- Over the past year, XYL TTM EBITDA has increased by +$573.00 million (+51.16%).
- XYL TTM EBITDA is now at all-time high.
Performance
XYL TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
XYL EBITDA Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +51.2% | +45.7% | +51.2% |
3 y3 years | +103.5% | +52.0% | +65.8% |
5 y5 years | +128.8% | +52.0% | +65.8% |
XYL EBITDA Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +133.2% | at high | +504.6% | at high | +155.7% |
5 y | 5-year | at high | +176.2% | at high | +504.6% | at high | +200.2% |
alltime | all time | at high | +349.1% | at high | +662.3% | at high | +1740.2% |
Xylem EBITDA History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2024 | $1.69 B(+51.2%) | $526.00 M(+25.2%) | $1.69 B(+10.8%) |
Sep 2024 | - | $420.00 M(+4.2%) | $1.53 B(+5.1%) |
Jun 2024 | - | $403.00 M(+17.2%) | $1.45 B(+14.6%) |
Mar 2024 | - | $344.00 M(-4.7%) | $1.27 B(+13.3%) |
Dec 2023 | $1.12 B(+54.3%) | $361.00 M(+4.3%) | $1.12 B(+9.7%) |
Sep 2023 | - | $346.00 M(+58.7%) | $1.02 B(+34.0%) |
Jun 2023 | - | $218.00 M(+11.8%) | $762.00 M(+1.3%) |
Mar 2023 | - | $195.00 M(-25.6%) | $752.00 M(+3.6%) |
Dec 2022 | $726.00 M(-12.7%) | $262.00 M(+201.1%) | $726.00 M(+9.7%) |
Sep 2022 | - | $87.00 M(-58.2%) | $662.00 M(-16.3%) |
Jun 2022 | - | $208.00 M(+23.1%) | $791.00 M(-1.6%) |
Mar 2022 | - | $169.00 M(-14.6%) | $804.00 M(-3.4%) |
Dec 2021 | $832.00 M(+35.7%) | $198.00 M(-8.3%) | $832.00 M(-4.9%) |
Sep 2021 | - | $216.00 M(-2.3%) | $875.00 M(+10.2%) |
Jun 2021 | - | $221.00 M(+12.2%) | $794.00 M(+15.4%) |
Mar 2021 | - | $197.00 M(-18.3%) | $688.00 M(+12.2%) |
Dec 2020 | $613.00 M(-17.2%) | $241.00 M(+78.5%) | $613.00 M(-2.7%) |
Sep 2020 | - | $135.00 M(+17.4%) | $630.00 M(+11.7%) |
Jun 2020 | - | $115.00 M(-5.7%) | $564.00 M(-17.8%) |
Mar 2020 | - | $122.00 M(-52.7%) | $686.00 M(-7.3%) |
Dec 2019 | $740.00 M(-20.3%) | $258.00 M(+273.9%) | $740.00 M(-0.8%) |
Sep 2019 | - | $69.00 M(-70.9%) | $746.00 M(-19.1%) |
Jun 2019 | - | $237.00 M(+34.7%) | $922.00 M(+0.1%) |
Mar 2019 | - | $176.00 M(-33.3%) | $921.00 M(-0.8%) |
Dec 2018 | $928.00 M(+18.7%) | $264.00 M(+7.8%) | $928.00 M(+4.5%) |
Sep 2018 | - | $245.00 M(+3.8%) | $888.00 M(+4.1%) |
Jun 2018 | - | $236.00 M(+29.0%) | $853.00 M(+4.5%) |
Mar 2018 | - | $183.00 M(-18.3%) | $816.00 M(+4.3%) |
Dec 2017 | $782.00 M | $224.00 M(+6.7%) | $782.00 M(+8.3%) |
Sep 2017 | - | $210.00 M(+5.5%) | $722.00 M(+10.2%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2017 | - | $199.00 M(+33.6%) | $655.00 M(+9.3%) |
Mar 2017 | - | $149.00 M(-9.1%) | $599.00 M(+6.8%) |
Dec 2016 | $561.00 M(-5.1%) | $164.00 M(+14.7%) | $561.00 M(-1.6%) |
Sep 2016 | - | $143.00 M(0.0%) | $570.00 M(-1.7%) |
Jun 2016 | - | $143.00 M(+28.8%) | $580.00 M(+0.7%) |
Mar 2016 | - | $111.00 M(-35.8%) | $576.00 M(-2.5%) |
Dec 2015 | $591.00 M(-4.2%) | $173.00 M(+13.1%) | $591.00 M(-0.5%) |
Sep 2015 | - | $153.00 M(+10.1%) | $594.00 M(-3.9%) |
Jun 2015 | - | $139.00 M(+10.3%) | $618.00 M(-2.2%) |
Mar 2015 | - | $126.00 M(-28.4%) | $632.00 M(+2.4%) |
Dec 2014 | $617.00 M(+22.7%) | $176.00 M(-0.6%) | $617.00 M(+2.5%) |
Sep 2014 | - | $177.00 M(+15.7%) | $602.00 M(+7.9%) |
Jun 2014 | - | $153.00 M(+37.8%) | $558.00 M(+8.8%) |
Mar 2014 | - | $111.00 M(-31.1%) | $513.00 M(+2.0%) |
Dec 2013 | $503.00 M(-14.0%) | $161.00 M(+21.1%) | $503.00 M(+3.9%) |
Sep 2013 | - | $133.00 M(+23.1%) | $484.00 M(-3.4%) |
Jun 2013 | - | $108.00 M(+6.9%) | $501.00 M(-9.6%) |
Mar 2013 | - | $101.00 M(-28.9%) | $554.00 M(-5.3%) |
Dec 2012 | $585.00 M(+8.9%) | $142.00 M(-5.3%) | $585.00 M(+1.7%) |
Sep 2012 | - | $150.00 M(-6.8%) | $575.00 M(+5.7%) |
Jun 2012 | - | $161.00 M(+22.0%) | $544.00 M(+1.9%) |
Mar 2012 | - | $132.00 M(0.0%) | $534.00 M(-0.4%) |
Dec 2011 | $537.00 M(+11.9%) | $132.00 M(+10.9%) | $536.00 M(-0.7%) |
Sep 2011 | - | $119.00 M(-21.2%) | $540.00 M(+1.7%) |
Jun 2011 | - | $151.00 M(+12.7%) | $531.00 M(+39.7%) |
Mar 2011 | - | $134.00 M(-1.5%) | $380.00 M(+12.4%) |
Dec 2010 | $480.00 M(+27.3%) | $136.00 M(+23.6%) | $338.00 M(+67.3%) |
Sep 2010 | - | $110.00 M(+19.6%) | $202.00 M(+119.6%) |
Mar 2010 | - | $92.00 M | $92.00 M |
Dec 2009 | $377.00 M | - | - |
FAQ
- What is Xylem annual EBITDA?
- What is the all time high annual EBITDA for Xylem?
- What is Xylem annual EBITDA year-on-year change?
- What is Xylem quarterly EBITDA?
- What is the all time high quarterly EBITDA for Xylem?
- What is Xylem quarterly EBITDA year-on-year change?
- What is Xylem TTM EBITDA?
- What is the all time high TTM EBITDA for Xylem?
- What is Xylem TTM EBITDA year-on-year change?
What is Xylem annual EBITDA?
The current annual EBITDA of XYL is $1.69 B
What is the all time high annual EBITDA for Xylem?
Xylem all-time high annual EBITDA is $1.69 B
What is Xylem annual EBITDA year-on-year change?
Over the past year, XYL annual EBITDA has changed by +$573.00 M (+51.16%)
What is Xylem quarterly EBITDA?
The current quarterly EBITDA of XYL is $526.00 M
What is the all time high quarterly EBITDA for Xylem?
Xylem all-time high quarterly EBITDA is $526.00 M
What is Xylem quarterly EBITDA year-on-year change?
Over the past year, XYL quarterly EBITDA has changed by +$165.00 M (+45.71%)
What is Xylem TTM EBITDA?
The current TTM EBITDA of XYL is $1.69 B
What is the all time high TTM EBITDA for Xylem?
Xylem all-time high TTM EBITDA is $1.69 B
What is Xylem TTM EBITDA year-on-year change?
Over the past year, XYL TTM EBITDA has changed by +$573.00 M (+51.16%)